Chronic diseases are the leading cause of mortality worldwide — representing more than 60% of all deaths.1,2 They’re also an enormous healthcare burden. They dramatically increase the odds of readmission for patients, including surgical patients with comorbidities. Seventy-eight percent of medical costs in the United States and 46 percent of worldwide costs are attributed to chronic disease.3
That’s where home surveillance comes in. For patients with chronic conditions like congestive heart failure and chronic obstructive pulmonary disease (COPD), home surveillance has been shown to:
Improve clinical outcomes4
Identify clinical deterioration early5
Reduce 30-day readmission6
Reduce the cost of care7
Geneia’s @Home remote patient monitoring program, powered by ZephyrLIFETM technology, is a 24x7x365 solution that helps chronically ill patients and their providers better understand, monitor and manage their health.
The @Home pilot study compared the experience of Capital BlueCross members diagnosed with heart failure (HF), who enrolled and actively participated in the @Home remote monitoring program, to a control group of non-monitored members with statistically similar pre-program risk scores.
Read the Press Release
Key results from the pilot include:
 |
 |
 |
 |
You have her back. So she can move forward. With the ZephyrLIFE™ Home monitoring system, you still have her back. Whether she needs your support for daily management of a chronic condition or she is recovering from surgery, this streamlined wireless technology provides you continuing clinical surveillance to help her manage her health. You get the information you need, when you need it. And your patient gets peace of mind.
Evidence demonstrates patient and cost benefits of telehealth and home surveillance monitoring
1. Chronic diseases and health promotion. World Health Organization. http://www.who.int/chp/en/. Accessed September 2014.
2. Global status report on noncommunicable diseases 2010. World Health Organization. http://www.who.int/nmh/publications/ncd_report2010/en/. Published April 2011. Accessed September 2014.
3. Pare G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic diseases: the evidence base. J Am Med Inform Assoc. 2007;14(3):269-277.
4. Jensen MH, Cichosz SL, Hejlesen OK, et al. Clinical impact of home telemonitoring on patients with chronic obstructive pulmonary disease. Telemed J E Health. 2012;18(9):674-678.
5. Clarke M, Fursse J, Jones RW. Early experiences of the use of remote patient monitoring for the long term management of chronic disease. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5863-5866.
6. Giordano A, Scalvini S, Zanelli E, et al. Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. Int J Cardiol. 2009;131(2):192-199.
7. Nguyen HQ, Chu L, Amy Liu IL, et al. Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(5):695-705.
8. http://www.prnewswire.com/news-releases/geneia-study-finds-remote-patient-monitoring-could-save-more-than-8000-per-patient-annually-300284802.html
9. National Health Service (NHS) in England and 3millionlives.co.uk/.
